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Dear Editor, 
With great interest we have read the article of Sène et al. (1) in which ectopic germinal centres (GCs) in 
labial gland biopsies of  primary Sjögren syndrome (pSS) patients were found predictive for Non-
Hodgkin’s lymphoma (NHL) development later in the disease. In the univariate analysis the presence of 
GCs in these biopsies was not significantly different between pSS patients that developed NHL or pSS 
patients that did not. However, multivariate analysis revealed that presence of GCs in biopsies was an 
independent predictor for NHL development (1). This study adds to the ongoing discussion about the 
presence of ectopic GCs in pSS diagnostic salivary gland biopsies as a risk factor for subsequent NHL 
development. The study of Theander et al. (2) showed that GCs in diagnostic labial gland biopsies was 
predictive for NHL development in pSS patients, whereas we (3) and others (4,5) did not detect such an 
association. As discussed extensively, (3,6) a major reason for the apparent discrepancy in the different 
studies was the variation in NHL-subtypes that were included.  
  Remarkably, half of the pSS patients in the study of Sène et al. (1) were male, whereas in the 
other studies that evaluated the presence of GCs as risk factor, the majority of patients (>81%) were 
females (2–5). Whether the predictive value of presence of GCs in diagnostic biopsies differs between 
males and females is not known.  
  A very unusual observation in the study of Sène et al. (1) was that all pSS patients who 
developed NHL, had a monoclonal gammopathy (MG). In pSS patients in general, the presence of MG 
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parotid MALT lymphoma (Haacke et al., unpublished data). In another recent study only 3/7 (43%) pSS 
patients with pulmonary MALT lymphomas exhibited MG (9). Presence of MG is known as a risk factor 
for NHL development, but is also associated with higher disease activity (8,10). The presence of MG in 
pSS pre-lymphoma patients in the study of Sène et al. (1), could thus also be a reflection of high 
disease activity (ESSDAI) which is an independent predictor for NHL development (11). 
  Also the presence of GCs in biopsies is associated with high disease status (12). Since disease 
activity as measured by ESSDAI can change over time, (13) the time point when the diagnostic pSS 
biopsy is taken, is of crucial importance. If a labial gland biopsy is taken during a period of relatively low 
disease activity, the likelihood of presence of GCs might consequently be low. On the other hand, when 
a diagnostic pSS salivary gland biopsy is taken in a period of high disease activity, the chance of 
finding GCs is higher.   
 Thus, both GCs and MG are associated with higher disease status, but there is no clear indication 
that presence of ectopic GCs is a prerequisite for MALT lymphoma development. There are many pSS 
patients with GCs in their salivary gland biopsies that do not develop NHL. Of note, presence of GCs is 
usually assessed in labial salivary glands, which are not the sites where MALT lymphoma preferentially 
develop. We conclude that for prediction of pSS patients who are at risk for NHL development, clinical 
and laboratory factors such as low C4, RF-positivity, presence of cryoglobulin, highly active disease, 
purpura, lymphadenopathy and especially persistent parotid enlargement (5,11,14) are more important 
than presence of GCs in diagnostic salivary gland biopsies.   
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